NL-OMON31299招募中不适用
Influence of B cell depletion therapy (rituximab) on (risk factors of) comorbidity in rheumatoid arthritis - B cell depletion therapy in rheumatoid arthritis and comorbidity
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 99(—)
入选标准
- •According to the thesis of the Dutch association of rheumatology (NVR): treatment with rituximab of rheumatoid arthritis patients:
- •- rheumatoid arthritis diagnosed according to the ACR criteria 1987
- •- active rheumatoid arthritis
- •- previous failure of TNF alpha blocking
排除标准
- •- malignity
- •- active tuberculosis or other active infection
- •- pregnancy and lactation
- •- severe heart failure (NYHA IV) or other cardiac disease
- •- hypersensitivity to one of the active substances of rituximab or murine proteins
研究者
相似试验
尚未招募
不适用
Study on the efficacy of rituximab in patients with polymyalgia rheumaticapolymyalgia rheumaticaNL-OMON27507one. This is an investigator initiated trial50
进行中(未招募)
不适用
Efficacy of B-cell depletion with rituximab on oral, ocular and general disease manifestations in patients with primary Sjögren diseasePreviously treated patients with primary Sjögrens diseaseMedDRA version: 8.0Level: PTClassification code 10040767EUCTR2005-004740-31-DKniversity of Copenhagen34
已完成
2 期
Effect of B-cell Depletion in Patients With Primary Sjögren's SyndromePrimary Sjögren's SyndromeHyposalivationFatigueXerostomiaKeratoconjunctivitis SiccaNCT00426543University of Copenhagen21
已完成
不适用
Effect of three B-cell inhibitors: rituximab, alemtuzumab and bortezomib on anti-A and/or anti-B titer kinetics.kidneytransplant1001884910038430NL-OMON39959eids Universitair Medisch Centrum24
尚未招募
2 期
Comparing Use of B-cell depletion therapy to Immunoglobulin in Chronic inflammatory demyelinating polyneuropathy (CUBIC) clinical trial.Chronic inflammatory demyelinating polyneuropathy (CIDP).Inflammatory and Immune System - Autoimmune diseasesNeurological - Other neurological disordersACTRN12623001336673Western Sydney Local Health District35
